Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Clarivate Plc Market Cap
From what 0 stock analysts predict, the share price for Clarivate Plc (CLVT) might increase by 12.91% in the next year. This is based on a 12-month average estimation for CLVT. Price targets go from $5 to $10. The majority of stock analysts believe CLVT is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
CLVT is a stock in Technology which has been forecasted to be worth $7.61 as an average. On the higher end, the forecast price is $10 USD by Owen Lau from Oppenheimer and on the lower end CLVT is forecasted to be $5 by Manav Patnaik from Barclays.
These are the latest 20 analyst ratings of CLVT.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Ashish Sabadra RBC Capital | Sector Perform | $7 | Maintains | Aug 7, 2024 |
| Manav Patnaik Barclays | Underweight | $5 | Maintains | Aug 7, 2024 |
| George Tong Goldman Sachs | Buy | $7.5 | Maintains | May 9, 2024 |
| Ashish Sabadra RBC Capital | Sector Perform | $8 | Maintains | Feb 28, 2024 |
| Toni Kaplan Morgan Stanley | Equal-Weight | $8 | Maintains | Feb 28, 2024 |
| Owen Lau Oppenheimer | Outperform | $10 | Maintains | Feb 28, 2024 |
| Manav Patnaik Barclays | Underweight | $6 | Maintains | Feb 28, 2024 |
| Owen Lau Oppenheimer | Outperform | $11 | Maintains | Jan 8, 2024 |
| Seth Weber Wells Fargo | Underweight | $8 | Downgrade | Dec 15, 2023 |
| Owen Lau Oppenheimer | Outperform | $10 | Maintains | Oct 5, 2023 |
| Peter Christiansen Citigroup | Neutral | $8 | Maintains | Sep 26, 2023 |
| Manav Patnaik Barclays | Underweight | $7 | Downgrade | Sep 8, 2023 |
| Ashish Sabadra RBC Capital | Sector Perform | $8 | Downgrade | Aug 25, 2023 |
| Heather Balsky B of A Securities | Underperform | $6 | Downgrade | Aug 7, 2023 |
| Seth Weber Wells Fargo | Equal-Weight | $8 | Downgrade | Aug 4, 2023 |
| George Tong Goldman Sachs | Buy | $9.5 | Maintains | Aug 4, 2023 |
| Ashish Sabadra RBC Capital | Outperform | $9 | Maintains | Aug 4, 2023 |
| Owen Lau Oppenheimer | Outperform | $11 | Maintains | Aug 4, 2023 |
| Toni Kaplan Morgan Stanley | Equal-Weight | $9 | Maintains | Aug 4, 2023 |
| Manav Patnaik Barclays | Equal-Weight | $8 | Maintains | Aug 4, 2023 |
When did it IPO
2006
Staff Count
12,000
Country
United Kingdom
Sector/Industry
Technology/Information Technology Services
CEO
Mr. Jonathan Gear
Market Cap
$4.77B
In 2023, CLVT generated $2.63B in revenue, which was a decrease of -1.17% from the previous year. This can be seen as a signal that CLVT's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 25 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Clarivate Plc (NYSE:CLVT) has announced a new framework to assess the societal impact of research, enhancing its offerings in transformative intelligence.
Why It Matters - Clarivate Plc's new framework for evaluating research impact could enhance its service offerings, attract more clients, and improve revenue potential, influencing stock performance positively.
Mon, 23 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Clarivate Plc has partnered with Relatable Healthcare to improve product data management and efficiency for medtech sales and pricing teams, enhancing revenue potential.
Why It Matters - The partnership enhances product data management for medtech firms, potentially increasing efficiency and revenue, which may positively impact Clarivate's market position and stock performance.
Tue, 24 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Clarivate Plc released a report offering insights and best practices for enhancing intellectual property operations, based on survey findings.
Why It Matters - Clarivate's new report on optimizing IP operations signals potential growth in the IP sector, impacting valuation and strategy for companies reliant on intellectual property.
Thu, 19 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Clarivate Plc released its 2024 Citation Laureatesâ„¢ list, identifying researchers with significant citation records and societal impact, indicating potential future Nobel Prize winners.
Why It Matters - The Citation Laureatesâ„¢ list can influence investor sentiment towards Clarivate Plc, as it underscores the company's role in identifying potential Nobel winners, enhancing its market credibility.
Wed, 18 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - The 15th annual Clarivate Pharmavision India conference will feature discussions on AI in healthcare, cell and gene therapy, and market access, highlighting industry advancements.
Why It Matters - The conference highlights advancements in AI and therapies, indicating potential growth areas in healthcare. This could drive investment opportunities in biotech and related sectors.
Wed, 18 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Clarivate Plc (NYSE: CLVT) has launched Primoâ„¢ Research Assistant, an AI tool aimed at enhancing library discovery and helping users find trusted content more easily.
Why It Matters - Clarivate's launch of Primoâ„¢ Research Assistant enhances library discovery, potentially boosting user engagement and demand for its services, impacting future revenue growth.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
